Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 1
1984 2
1985 5
1986 1
1987 4
1988 4
1989 2
1990 5
1991 1
1992 4
1993 1
1994 2
1995 2
1996 7
1997 2
1998 2
1999 1
2000 1
2001 3
2002 2
2003 1
2004 5
2005 2
2007 1
2008 2
2009 4
2011 1
2012 2
2013 1
2015 2
2016 3
2017 1
2018 5
2019 3
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Issels RD, Lindner LH, Verweij J, Wessalowski R, Reichardt P, Wust P, Ghadjar P, Hohenberger P, Angele M, Salat C, Vujaskovic Z, Daugaard S, Mella O, Mansmann U, Dürr HR, Knösel T, Abdel-Rahman S, Schmidt M, Hiddemann W, Jauch KW, Belka C, Gronchi A; European Organization for the Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group and the European Society for Hyperthermic Oncology. Issels RD, et al. Among authors: Mella O. JAMA Oncol. 2018 Apr 1;4(4):483-492. doi: 10.1001/jamaoncol.2017.4996. JAMA Oncol. 2018. PMID: 29450452 Free PMC article. Clinical Trial.
Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.
Fluge Ø, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, Rekeland IG, Sapkota D, Røsland GV, Fosså A, Ktoridou-Valen I, Lunde S, Sørland K, Lien K, Herder I, Thürmer H, Gotaas ME, Baranowska KA, Bohnen LM, Schäfer C, McCann A, Sommerfelt K, Helgeland L, Ueland PM, Dahl O, Tronstad KJ. Fluge Ø, et al. Among authors: Mella O. JCI Insight. 2016 Dec 22;1(21):e89376. doi: 10.1172/jci.insight.89376. JCI Insight. 2016. PMID: 28018972 Free PMC article.
Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.
Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, Meisel C, Reinke P, Volk HD, Fluge Ø, Mella O, Scheibenbogen C. Loebel M, et al. Among authors: Mella O. Brain Behav Immun. 2016 Feb;52:32-39. doi: 10.1016/j.bbi.2015.09.013. Epub 2015 Sep 21. Brain Behav Immun. 2016. PMID: 26399744 Free article.
Kronisk utmattelsessyndrom og pyruvat dehydrogenasefunksjon.
Tronstad KJ, Fluge Ø, Mella O. Tronstad KJ, et al. Among authors: Mella O. Tidsskr Nor Laegeforen. 2018 Jan 8;138(1). doi: 10.4045/tidsskr.17.1086. Print 2018 Jan 9. Tidsskr Nor Laegeforen. 2018. PMID: 29313610 Free article. Norwegian. No abstract available.
Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Günther OP, Gardy JL, Stafford P, Fluge Ø, Mella O, Tang P, Miller RR, Parker SM, Johnston SA, Patrick DM. Günther OP, et al. Among authors: Mella O. Mol Neurobiol. 2019 Jun;56(6):4249-4257. doi: 10.1007/s12035-018-1354-8. Epub 2018 Oct 8. Mol Neurobiol. 2019. PMID: 30298340 Free PMC article. Clinical Trial.
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study.
Fluge Ø, Mannsåker B, Torp A, Mjaaland I, Helgeland L, Klos J, Mella O, Berentsen S, Meyer P. Fluge Ø, et al. Among authors: Mella O. Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):125-135.e3. doi: 10.1016/j.clml.2017.12.002. Epub 2017 Dec 24. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29352718 Free article.
Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
Lunde S, Kristoffersen EK, Sapkota D, Risa K, Dahl O, Bruland O, Mella O, Fluge Ø. Lunde S, et al. Among authors: Mella O. PLoS One. 2016 Aug 18;11(8):e0161226. doi: 10.1371/journal.pone.0161226. eCollection 2016. PLoS One. 2016. PMID: 27536947 Free PMC article. Clinical Trial.
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
Fluge Ø, Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, Kristoffersen EK, Sørland K, Bruland O, Dahl O, Mella O. Fluge Ø, et al. Among authors: Mella O. PLoS One. 2015 Jul 1;10(7):e0129898. doi: 10.1371/journal.pone.0129898. eCollection 2015. PLoS One. 2015. PMID: 26132314 Free PMC article. Clinical Trial.
B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Fluge Ø, Rekeland IG, Lien K, Thürmer H, Borchgrevink PC, Schäfer C, Sørland K, Aßmus J, Ktoridou-Valen I, Herder I, Gotaas ME, Kvammen Ø, Baranowska KA, Bohnen LMLJ, Martinsen SS, Lonar AE, Solvang AH, Gya AES, Bruland O, Risa K, Alme K, Dahl O, Mella O. Fluge Ø, et al. Among authors: Mella O. Ann Intern Med. 2019 May 7;170(9):585-593. doi: 10.7326/M18-1451. Epub 2019 Apr 2. Ann Intern Med. 2019. PMID: 30934066 Clinical Trial.
Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome.
Rekeland IG, Fluge Ø, Alme K, Risa K, Sørland K, Mella O, de Vries A, Schjøtt J. Rekeland IG, et al. Among authors: Mella O. Clin Ther. 2019 May;41(5):806-814. doi: 10.1016/j.clinthera.2018.10.019. Epub 2018 Nov 28. Clin Ther. 2019. PMID: 30502905
85 results
Jump to page
Feedback